The introduction of invasive aquatic species in new environments has been identified as one of the four biggest threats to the world's oceans causing serious threats and harm to both ecology and human health. There is a major exchange of ship’s ballast water over longer distances between continents and regional seas, and it has been known for decades that ballast water transfers organisms to new ecosystems, where the strongest, most aggressive and adaptable species can survive and become invasive under favourable conditions. The focus of the research is to study available ballast water control technologies to determine their suitability and effectiveness in the reduction of harmful aquatic organisms and compounds in the Baltic Sea.
The article discusses the possible relationships between intestinal microbiota and the therapeutic efficacy of 5-aminosalicylic acid (5-ASA) in inflammatory bowel diseases. Intestinal microbiota may be involved in 5-ASA enzymatic biotransformation, but the metabolism of drugs by the intestinal microbiota has been studied in less detail, and little is known about the relationships between anti-inflammatory efficacy of 5-ASA with bacterial viability, quantity and activity. It remains unclear whether 5-ASA affects the microbiota depending on the different segments of gastrointestinal tract. Drugs and diet can both improve and worsen the composition of the intestinal microbiota. However, it is not known whether drugs affect the intestinal microbiota regardless of diet. Further research is needed to answer these questions.